Table 1.
Studies on prevalence of active tuberculosis included in the systematic review and their characteristics (n = 46)
First Author | Year of publication | Country of study | Population | Country / Region of origin | Period of data collection | Setting | Sample size (n) |
Study design | Women (%) |
Bacteriologically confirmed | Prevalence of Active TB (per 100,000 inhabitants) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Start | End | Men | Women | Overall | ||||||||||
Mockenhaupt [32] | 2016 | Germany | Refugee | Syria | 2011 | 2015 | Routine screening | 44 b | Cohort | 34.1 | NI | NI | NI | 11,364 |
Nisbet [4] | 2007 | New Zealand | Refugee | Ethiopia; Somalia; Vietnam | 1993 | 2004 | Routine screening | 98 b | Cohort | 44.0 | NI | NI | NI | 10,204 |
Ravensbergen [33] | 2016 | Netherlands | Asylum Seeker | Eritrea; Syria; Afghanistan; Armenia; Nigeria | 2014 | 2015 | Routine screening | 736 a, b | Cross sectional | 32.6 | Yes | NI | NI | 6250 |
Rajamanoharan [34] | 2004 | UK | Mixed | Africa; Eastern Europe; Middle East; South America; Asia | 2001 | 2002 | NI | 1856 b | Cross sectional | NI | NI | NI | NI | 6627 |
Marras [35] | 2003 | Canada | Refugee | India; Tibet; Nepal | 1998 | 2001 | Routine screening | 525 b | Cohort | 32.0 | Yes | NI | NI | 5905 |
Lee [36] | 2013 | USA | Refugee | Iraq; Burma; Bhutan; Iran; Cuba; Thailand; Vietnam; Nepal; Somalia | 2009 | 2009 | Routine screening | 78,899 b | Cross sectional | NI | Yes | NI | NI | 4349 |
Lobue [37] | 2004 | USA | Refugee | NI | 2001 | 2003 | Routine screening | 54 b | Cohort | NI | Yes | NI | NI | 3704 |
Gray [38] | 2012 | Australia | Refugee | Middle East; Africa; Asia; Australia | 2005 | 2010 | Routine screening | 328 b | Cross sectional | 45.7 | No | NI | NI | 3354 |
Banfield [39] | 2012 | Australia | Refugee | Sudan; Congo; Liberia; Burundi; Tanzania; Sierra Leone; Burma | 2006 | 2007 | Routine screening | 264 c | Cross sectional | 51.2 | No | NI | NI | 3030 |
Otoukesh [40] | 2012 | Iran | Refugee | Afghanistan | 2005 | 2010 | Routine screening | 23,152 b | Cross sectional | 52.3 | NI | 2.01 | 3.16 | 2613 |
Dierberg [41] | 2016 | India | Refugee | Tibet | 2011 | 2013 | NI | 3830 c | Cohort | 35.7 | Yes | 3.12 | 1.39 | 2507 |
Tiong [42] | 2006 | Australia | Refugee | Western Africa; Central Africa; Eastern Africa; Africa | 2004 | 2005 | Both | 84 c | Cross sectional | 55.8 | No | NI | NI | 2381 |
Chaves [43] | 2009 | Australia | Refugee | Myanmar; Thailand | 2004 | 2008 | Symptomatic | 149 a, c | Cohort | 48.7 | Yes | NI | NI | 2013 |
Sheikh [44] | 2009 | Australia | Refugee | Asia; Middle East; Western Africa; Central Africa; Eastern Africa | 2005 | 2006 | Routine screening | 219 c | Cross sectional | 53.1 | No | NI | NI | 1826 |
Lowther [45] | 2012 | USA | Refugee | Sub-Saharan Africa; South and Southeast Asia | 2000 | 2007 | Routine screening | 11,615c | Cohort | 44.8 | Yes | NI | NI | 1817 |
Oeltmann [46] | 2008 | USA | Refugee | Thailand | 2004 | 2005 | Routine screening | 15,455b | Cross sectional | 41.2 | Yes | NI | NI | 1760 |
Sarivalasis [47] | 2012 | Switzerland | Asylum Seeker | Balkan Peninsula; Soviet Union; Asia; Africa | 2009 | 2010 | Routine screening | 393c | Cross sectional | 27.2 | Yes | 1.40 | 0.93 | 1272 |
Harstad [48] | 2010 | Norway | Asylum Seeker | Iraq; Somalia; Russia; Afghanistan; Serbia and Montenegro | 2005 | 2008 | Routine screening | 2237b | Cohort | 30.1 | Yes | 0.83 | 2.23 | 1252 |
Varkey [49] | 2007 | USA | Refugee | Africa; Europe; Asia; Central and South America | 1997 | 2001 | Routine screening | 9842c | Cohort | 47.7 | Yes | 1.13 | 0.65 | 1179 |
Choi [6] | 2007 | Republic of Korea | Refugee | North Korea | 1999 | 2006 | Routine screening | 7722 b | Cross sectional | 63.4 | Yes | 1.34 | 1.00 | 1127 |
Soydan [50] | 2017 | Turkey | Mixed | NI | 2013 | 2015 | Symptomatic | 1149a, b | Cross sectional | 47,3 | No | 0.82 | 1.10 | 957 |
Bua [51] | 2016 | Italy | Mixed | Nigeria; Mali; Senegal; Bangladesh; Gambia; Guinea; Nigeria; Ghana; Togo | NI | NI | Routine screening | 109b | Cross sectional | NI | Yes | NI | NI | 917 |
Diel [52] | 2004 | Germany | Asylum Seeker | Afghanistan; Turkey; Iran; Burkina Faso; Socialist Federal Republic of Yugoslavia; Sierra Leone; Russia; Guinea; Togo | 1997 | 2002 | Both | 12,176b | Cohort | NI | Yes | NI | NI | 887 |
Bennet [53] | 2017 | Sweden | Asylum Seeker | Afghanistan; Somalia; Eritrea; Ethiopia | 2015 | 2016 | Routine screening | 2936 b | Cohort | NI | Yes | NI | NI | 817 |
Tafuri [10] | 2011 | Italy | Asylum Seeker | Asia; Eritrea; Gambia; Ghana; Nigeria; North Africa; Somalia; Tunisia | 2009 | 2009 | Routine screening | 982c | Cross sectional | 14.4 | Yes | NI | NI | 815 |
Russo [54] | 2016 | Italy | Asylum Seeker | Africa; Asia; South America | 2012 | 2013 | Symptomatic | 792c | Cross sectional | 20,1 | No | NI | NI | 758 |
Lalchandani [55] | 2001 | Ireland | Refugee | Africa; Romania; Kosovo; Russia | 1999 | 2000 | Routine screening | 271a, b | Cross sectional | 100 | NI | NI | NI | 738 |
Johnston [56] | 2012 | Australia | Refugee | Asia; Africa | 2009 | 2010 | Routine screening | 176 c | Cohort | 41.7 | NI | NI | NI | 568 |
Lim [57] | 2016 | Canada | Refugee | Tibet | 2014 | 2016 | Routine screening | 180 b | Cohort | 51,1 | Yes | NI | NI | 556 |
Hobbs [58] | 2002 | New Zealand | Asylum Seeker | Iran; Afghanistan; Siri Lanka; Czech Republic; Kuwait; Somalia; Iraq | 1999 | 2000 | Routine screening | 780 c | Cross sectional | 31.9 | No | NI | NI | 513 |
Lobato [59] | 2008 | USA | Refugee | Bosnia; Vietnam, Somalia; Congo; Eritrea; Haiti; Cambodia | 1996 | 2005 | Routine screening | 4904 c | Cohort | NI | Yes | NI | NI | 510 |
Winje [60] | 2008 | Norway | Asylum Seeker | Asia. Europe; Africa | 2005 | 2006 | Routine screening | 1000 b | Cross sectional | 24.9 | Yes | NI | NI | 500 |
Liu [61] | 2015 | USA | Refugee | NI | 2007 | 2012 | Routine screening | 232,738 b | Cross sectional | NI | Yes | NI | NI | 474 |
Rennert-May [62] | 2016 | Canada | Refugee | Sub-Saharan Africa; Middle East; South Asia; East and Southeast Asia | 2009 | 2011 | Routine screening | 746 c | Cohort | 50.1 | Yes | NI | NI | 402 |
Sane Schepisi [63] | 2013 | Italy | Mixed | NI | 2009 | 2010 | Routine screening | 776 b | Cross sectional | NI | Yes | NI | NI | 258 |
Chai [64] | 2013 | USA | Mixed | Ethiopia; Cameroon; Eritrea; Sierra Leone; Togo; Vietnam; Sudan; Democratic Republic of Congo; Columbia | 2003 | 2007 | Routine screening | 781 b | Cohort | 43.0 | NI | NI | NI | 256 |
Trauer [65] | 2011 | Australia | Refugee | Africa; Eastern Mediterranean; Southeast Asia | 2006 | 2009 | Routine screening | 471 b | Cohort | 56.1 | Yes | NI | NI | 212 |
Gibson-Helm [66] | 2015 | Australia | Refugee | Siri Lanka; Afghanistan; India; Mauritius; Vietnam; Iraq; Indonesia; Pakistan; Philippines; | 2002 | 2011 | Routine screening | 13,319 b | Cross sectional | 100.0 | NI | NI | NI | 188 |
Schneeberger Geisler [67] | 2010 | Switzerland | Asylum Seeker | NI | 2004 | 2008 | Routine screening | 45,129 b | Cross sectional | 25.1 | Yes | 0.15 | 0.09 | 168 |
Harling [68] | 2007 | UK | Asylum Seeker | Iraq; Afghanistan; Czech Republic; Iran; Congo; Somalia; Zimbabwe; Angola | 2002 | 2003 | Routine screening | 8258 b | Cross sectional | 25.0 | Yes | NI | NI | 133 |
Meier [69] | 2016 | Germany | Asylum Seeker | NI | 2014 | 2015 | Routine screening | 11,773 b | Cross sectional | NI | Yes | NI | NI | 93 |
Bloch-Infanger [70] | 2017 | Switzerland | Asylum Seeker | NI | 2004 | 2015 | Routine screening | 8697 b | Cross sectional | NI | No | NI | NI | 69 |
Weinrich [71] | 2017 | Germany | Refugee | NI | 2015 | 2015 | Routine screening | 17,487 b | Cross sectional | 23,0 | No | NI | NI | 57 |
Yanni [72] | 2013 | Jordan | Refugee | Iraq | 2007 | 2009 | Routine screening | 14,077 c | Cohort | 50.3 | Yes | NI | NI | 7 |
Subedi [73] | 2015 | USA | Refugee | Bhutan; Burma | 2010 | 2012 | Routine screening | 149 b | Cohort | 46.3 | Yes | NI | NI | 0 |
Paxton [74] | 2012 | Australia | Refugee | NI | 2006 | 2009 | Routine screening | 810 c | Cross sectional | 49.0 | No | NI | NI | 0 |
Abbreviations: USA United States of America, UK United Kingdom, NI Not Informed, TB Tuberculosis
In the column Setting, “both” means that the study performed routine screening and symptomatic evaluation
aHospitalised population; bTotal population on study; cPopulation screened for active tuberculosis